Myeloma Today Spring 2006 Volume 6 Issue 8

What Is Multiple Myeloma?

Multiple myeloma is a cancer of the bone marrow plasma cells. It is synonymous with "myeloma" and "plasma cell myeloma." Plasma cells make antibodies against infectious agents such as viruses and bacteria. A cancerous or malignant plasma cell is called a myeloma cell. Myeloma is called “multiple” because there are frequently multiple patches or areas in bone marrow where it grows.

Focus on Myeloma and Plasma Cell Disorders; Conference Overview with Morton Coleman, MD
Update on the Role of Lenalidomide (Revlimid®) in Myeloma
The Role of Bortezomib in Previously Untreated Myeloma
The Efficacy of Thalidomide in the Treatment of Myeloma
Research Project Abstract: Gene Targeting and Cell Therapy for Refractory Myeloma
Current Imaging of Myeloma
IMF Research Grant Funded by Donate for Drew Day: "Novel Therapeutic Antibodies for Multiple Myeloma"
Two Myeloma Meetings Held in Germany; Patient Day and Expert Symposium in Heidelberg
San Francisco IMF Patient & Family Seminar
Ft. Lauderdale IMF Patient & Family Seminar
IMF Latin America
Nutrition and Multiple Myeloma
IMF Hotline Coordinators Answer Your Questions: How to Cope with Peripheral Neuropathy
The Atlanta Area Multiple Myeloma Support Group
Preview of the IMF Support Group Leaders' Retreat
Living Sucessfully with Multiple Myeloma
Family and Friends Celebrate the Life of Mario Federis
IMF Honors Member Event Through Research Grant; "J.C." Johnson's Family and Friends Raise $90,000 to Fight Myeloma
Music Against Myeloma
Our Guiding Light Shines Bright
Scientific Advisor Profile: A. Keith Stewart, MB, CHB, MBA
Board of Directors Profile: Igor Sill
News and Notes
Letters to the IMF